Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media

• Status: Completed
• Trial end date: 2006-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to assess in France the impact of Prevenar on the possible evolution of the pneumococcal serotypes distribution and antibiotic resistance in NP samples of children with AOM.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
• Treatments: Heptavalent Pneumococcal Conjugate Vaccine

Criteria

Inclusion Criteria:

• Infants aged from 6 to 24 months

• Presenting with AOM (ear infection)

• Patients must not have received any antibiotic therapy within the past 7 days.

Other inclusion applies.

Exclusion Criteria: